Texas A&M professor Simrit Parmar has invented a therapy that has been shown to improve patients suffering from diseases like ...

“Stem cells have great potential to stimulate the regeneration of damaged cartilage, thereby helping to restore joint function without the need for invasive joint replacement surgery,” he said in an ...

Banking a baby’s umbilical cord blood was once seen as a reasonable way to protect their future health, but much of that ...

Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the ...

Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-stage biotech company Cellenkos Inc. in Houston, ...

The Global Stem Cell Therapy Market is set to witness a healthy growth rate of 20% by 2029. A favorable investment ...

Press ReleaseIB [email protected] NextCell announces strategic collaboration with Fujifilm Irvine ScientificHuddinge, Sweden, May 20, 2025 – NextCell Pharma AB ("NextCell" or "the ...

NextCell Pharma AB's ("NextCell" or "the Company") has entered into a strategic collaboration with Fujifilm Irvine Scientific Inc. to bring together their core competences in mesenchymal stromal cells ...

Although performing hematopoietic stem cell transplantation with umbilical cord blood RBCs has been a standard of care as a life-saving treatment among those with a variety of malignant and benign ...

and the treatment’s results offer new hope for patients battling this debilitating issue. Dr. Maysoon Al Karam, Chief Medical Officer at Abu Dhabi Stem Cells Center, said, “The effectiveness of two ...